Table 2.
Sample | Total mortality | |||||
Model 1† | Model 2‡ | |||||
Swedish | Danish | Pooled | Swedish | Danish | Pooled | |
No. of cases/censored* | 316/831 | 309/950 | 625/1781 | 314/821 | 292/893 | 606/1714 |
Height loss (cm) | 1.18 (1.09 to 1.28) | 1.24 (1.13 to 1.37) | 1.20 (1.13 to 1.27) | 1.14 (1.05 to 1.23) | 1.21 (1.09 to 1.35) | 1.15 (1.09 to 1.23) |
Height loss, binary | ||||||
Stable (≤2 cm) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
Major height loss (>2 cm) | 1.86 (1.41 to 2.44) | 1.90 (1.36 to 2.64) | 1.85 (1.50 to 2.29) | 1.74 (1.32 to 2.29) | 1.80 (1.27 to 2.54) | 1.74 (1.41 to 2.16) |
Pooled sample | Total CVD mortality | Stroke mortality | Non-CVD mortality | |||
Model 1† | Model 2‡ | Model 1† | Model 2‡ | Model 1† | Model 2‡ | |
No. of cases/censored* | 157/2249 | 156/2164 | 37/2369 | 36/2284 | 362/2044 | 347/1973 |
Height loss (cm) | 1.28 (1.17 to 1.40) | 1.21 (1.10 to 1.32) | 1.36 (1.15 to 1.61) | 1.30 (1.09 to 1.55) | 1.18 (1.09 to 1.28) | 1.14 (1.05 to 1.24) |
Height loss, binary | ||||||
Stable (≤2 cm) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
Major height loss (>2 cm) | 2.44 (1.69 to 3.53) | 2.14 (1.47 to 3.12) | 2.81 (1.38 to 5.75) | 2.31 (1.09 to 4.87) | 1.78 (1.34 to 2.36) | 1.71 (1.28 to 2.29) |
*Number of deaths since second height measure/censored at end of follow-up.
†Model 1 adjusted for age at follow-up, age2, time interval and height at baseline. Analyses of pooled sample also adjusted for cohort (Swedish/Danish).
‡Model 2 adjusted for age at follow-up, age2, time interval, height at baseline, weight at baseline, baseline smoking status, alcohol intake at baseline, baseline education and leisure time physical activity at baseline and follow-up. Analyses of pooled sample also adjusted for cohort (Swedish/Danish).